Harmony Biosciences Holdings Inc. (HRMY)
HRMY trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$37.03
-3.14% on the day
Market cap
$2.2B
Mid cap
Revenue · 2025
$868.5M
+21.5% on 2024
Net income · 2025
$158.7M
18.3% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | HRMY on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2020 |
| SEC CIK | 0001802665 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $868.5M |
| Net income | $158.7M |
| Operating income | $208.5M |
| Net margin | 18.3% |
| Operating margin | 24.0% |
| Revenue growth | +21.5% |
| Cash | $752.5M |
| Total assets | $1.3B |
| P/E (computed) | 13.6× |
| P/S (computed) | 2.5× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3ASR | 2025-02-25 |
| Latest annual report | 10-K | 2026-02-24 |
| Latest quarterly / interim | 10-Q | 2026-08-04 |
| Latest current report | 8-K | 2026-10-13 |
| Latest proxy | DEFA14A | 2026-04-03 |
Source: SEC EDGAR submissions feed, 456 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -4.1% |
| 1 month | -10.5% |
| 3 months | +12.5% |
| Year to date | +0.8% |
| 1 year | +43.1% |
| From 52-week high | -12.0% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| IRON | Disc Medicine Inc. | $56.60 | -6.42% | $2.2B |
| AUPH | Aurinia Pharmaceuticals Inc | $16.36 | -1.15% | $2.2B |
| PRGO | Perrigo Company plc | $15.37 | -0.52% | $2.1B |
| BHC | Bausch Health Companies Inc. | $5.89 | -0.68% | $2.2B |
| PHVS | Pharvaris N.V. | $30.02 | -2.82% | $2.1B |
| IMNM | Immunome Inc. | $17.58 | -8.20% | $2.1B |
| VRDN | Viridian Therapeutics Inc. | $18.22 | -0.44% | $2.1B |
| NRIX | Nurix Therapeutics Inc. | $22.13 | -0.14% | $2.3B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier